Immunogenicity, safety, and efficacy of rurioctocog alfa pegol in previously untreated patients with severe hemophilia A.

Sidonio RF Jr, Mullins ES, Peyvandi F, Chan AKC, Stasyshyn O, Yeoh SL, Sosothikul D, Antmen AB, El-Kamary SS, Gu J, Tangada S

Open source

DOI
10.1016/j.rpth.2026.106939
Published
2026 Aug
Container
Research and practice in thrombosis and haemostasis
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.rpth.2026.106939,
  title = {Immunogenicity, safety, and efficacy of rurioctocog alfa pegol in previously untreated patients with severe hemophilia A.},
  author = {Sidonio RF Jr and Mullins ES and Peyvandi F and Chan AKC and Stasyshyn O and Yeoh SL and Sosothikul D and Antmen AB and El-Kamary SS and Gu J and Tangada S},
  year = {2026},
  journal = {Research and practice in thrombosis and haemostasis},
  doi = {10.1016/j.rpth.2026.106939},
  url = {https://doi.org/10.1016/j.rpth.2026.106939}
}

RIS

TY  - JOUR
TI  - Immunogenicity, safety, and efficacy of rurioctocog alfa pegol in previously untreated patients with severe hemophilia A.
AU  - Sidonio RF Jr
AU  - Mullins ES
AU  - Peyvandi F
AU  - Chan AKC
AU  - Stasyshyn O
AU  - Yeoh SL
AU  - Sosothikul D
AU  - Antmen AB
AU  - El-Kamary SS
AU  - Gu J
AU  - Tangada S
PY  - 2026
JO  - Research and practice in thrombosis and haemostasis
DO  - 10.1016/j.rpth.2026.106939
UR  - https://doi.org/10.1016/j.rpth.2026.106939
ER  - 

APA

Jr, S. R., ES, M., F, P., AKC, C., O, S., SL, Y., D, S., AB, A., SS, E., J, G., & S, T. (2026). Immunogenicity, safety, and efficacy of rurioctocog alfa pegol in previously untreated patients with severe hemophilia A.. Research and practice in thrombosis and haemostasis. https://doi.org/10.1016/j.rpth.2026.106939

Source records